Batiraxcept (AVB-500)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Batiraxcept (AVB-500), covering 2024-10-02 to 2024-10-02. Get the full timeline:
Most recent: Clinical Trial Update: AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer [Phase 1]